Showing results (1651-1660 of 1,949) with videos related to
Sort By:
Pageof 195
Journal of Gastroenterology and Hepatology|March 23, 2012
Differential prognostic impact of renal insufficiency on patients with hepatocellular carcinoma: a propensity score analysis and staging strategyChia-Yang Hsu, Cheng-Yuan Hsia, Yi-Hsiang Huang, et al.Journal of Gastroenterology and Hepatology|June 23, 2021
Tumor burden score as a new prognostic marker for patients with hepatocellular carcinoma undergoing transarterial chemoembolizationShu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, et al.American Journal of Cancer Research|May 9, 2022
Proton beam radiotherapy combined with anti-PD1/PDL1 immune checkpoint inhibitors for advanced hepatocellular carcinomaChung-Wei Su, Ming-Mo Hou, Pei-Wei Huang, et al.Frontiers in Endocrinology|July 5, 2022
Association of Famine Exposure on the Changing Clinical Phenotypes of Primary Hyperparathyroidism in 20 yearsTian-Jiao Yuan, Yu-Ying Yang, Min-Ting Zhu, et al.Journal of Vascular and Interventional Radiology : JVIR|December 18, 2020
Outpatient Percutaneous Endovascular Abdominal Aortic Aneurysm Repair: A Single-Center ExperienceTzu-Chin Lo, Chun-Hsien Hsin, Ren-Fu Shie, et al.Plos One|June 7, 2014
A new Child-Turcotte-Pugh class 0 for patients with hepatocellular carcinoma: determinants, prognostic impact and ability to improve the current staging systemsYun-Hsuan Lee, Chia-Yang Hsu, Chen-Wei Chu, et al.Frontiers in Cardiovascular Medicine|August 6, 2024
Real-world experience of angiotensin receptor-neprilysin inhibitors in patients with heart failure and dialysisI-Ning Yang, Chi-Ya Huang, Chun-Ting Yang, et al.European Journal of Gastroenterology & Hepatology|May 4, 2011
Risk factors for long-term prognosis in hepatocellular carcinoma after radiofrequency ablation therapy: the clinical implication of aspartate aminotransferase-platelet ratio indexWei-Yu Kao, Yi-You Chiou, Hung-Hsu Hung, et al.Journal of Ethnopharmacology|December 15, 2016
Clinical efficacy of Rong-Yang-Jyh-Gan-Tang on patients with chronic hepatitis C: A double-blinded randomized placebo-controlled crossover studyFang-Pey Chen, Ching-Mao Chang, Ta-Peng Wu, et al.Life Sciences|February 12, 2021
Celecoxib ameliorates liver cirrhosis via reducing inflammation and oxidative stress along spleen-liver axis in ratsShihang Tang, Zhiyin Huang, Jingsun Jiang, et al.Pageof 195